We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
LSI Industries
LYTS
$924M
| $1.51M | ﹤0.01% |
100,143
-33,635
| -25% | -$476K |
|
1652
Vodafone
VOD
$37.4B
| $1.51M | ﹤0.01% |
169,900
-1,677,354
| -91% | -$14.6M |
|
|
BAYA
1653
DELISTED
Bayview Acquisition Corp
BAYA
| $1.51M | ﹤0.01% |
150,000
| – | – |
|
|
SCS
1654
DELISTED
Steelcase
SCS
| $1.51M | ﹤0.01% |
115,374
-339,390
| -75% | -$4.36M |
|
1655
LPL Financial
LPLA
$28.6B
| $1.51M | ﹤0.01% |
5,703
+1,003
| +21% | +$253K |
|
1656
Yext
YEXT
$574M
| $1.51M | ﹤0.01% |
249,722
-51,824
| -17% | -$306K |
|
|
TCN
1657
DELISTED
Tricon Residential Inc.
TCN
| $1.51M | ﹤0.01% |
135,029
+63,147
| +88% | +$673K |
|
|
BCIC
1658
BCP Investment Corp
BCIC
$92.9M
| $1.5M | ﹤0.01% |
79,259
-38,619
| -33% | -$722K |
|
1659
Atea Pharmaceuticals
AVIR
$420M
| $1.5M | ﹤0.01% |
372,250
+210,341
| +130% | +$823K |
|
1660
Capital One
COF
$134B
| $1.5M | ﹤0.01% |
10,100
-6,100
| -38% | -$826K |
|
1661
Molson Coors Class B
TAP
$8.09B
| $1.5M | ﹤0.01% |
22,314
-226,666
| -91% | -$14.4M |
|
|
B
1662
DELISTED
Barnes Group Inc.
B
| $1.5M | ﹤0.01% |
+40,359
| New | +$1.39M |
|
1663
Oric Pharmaceuticals
ORIC
$1.4B
| $1.5M | ﹤0.01% |
109,009
+3,999
| +4% | +$47.5K |
|
1664
FIVE9
FIVN
$2.54B
| $1.5M | ﹤0.01% |
24,106
-3,494
| -13% | -$243K |
|
1665
Central Pacific Financial
CPF
$1B
| $1.5M | ﹤0.01% |
75,734
-13,806
| -15% | -$264K |
|
|
BRSL
1666
Brightstar Lottery PLC
BRSL
$2.03B
| $1.49M | ﹤0.01% |
66,047
-32,000
| -33% | -$802K |
|
|
WCC
1667
WESCO International
WCC
$17.7B
| $1.49M | ﹤0.01% |
8,700
+200
| +2% | +$33K |
|
1668
Absci
ABSI
$1.51B
| $1.49M | ﹤0.01% |
262,209
+243,698
| +1,317% | +$1.1M |
|
1669
ExxonMobil
XOM
$634B
| $1.49M | ﹤0.01% |
12,810
-123,862
| -91% | -$13M |
|
1670
Navient
NAVI
$853M
| $1.49M | ﹤0.01% |
85,552
-21,469
| -20% | -$362K |
|
1671
Old Second Bancorp
OSBC
$1.29B
| $1.49M | ﹤0.01% |
107,375
+12,813
| +14% | +$179K |
|
|
HOLX
1672
DELISTED
Hologic
HOLX
| $1.49M | ﹤0.01% |
19,054
-514,555
| -96% | -$38.3M |
|
1673
Driven Brands
DRVN
$2.2B
| $1.48M | ﹤0.01% |
+93,806
| New | +$1.3M |
|
1674
Coherent
COHR
$74.2B
| $1.48M | ﹤0.01% |
24,395
-28,005
| -53% | -$1.54M |
|
1675
International Money Express
IMXI
$367M
| $1.48M | ﹤0.01% |
64,654
+46,658
| +259% | +$980K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.